Risankizumab compared with secukinumab in 52-week psoriasis trialJune 23, 2020PsoriasisPsoriatic Arthritis
Psoriasis topical combination maintenance strategy hits mark in phase 3June 16, 2020PsoriasisPsoriatic Arthritis
Entheseal lesions, bone density linked with incident PsA in psoriasis patientsJune 11, 2020Psoriatic Arthritis
EULAR’s COVID-19 recommendations offer no surprisesJune 11, 2020Psoriatic ArthritisPediatricsCOVID-19 Updates
Age leads COVID-19 hospitalization risk factors in RMDsJune 10, 2020COVID-19 UpdatesPsoriatic Arthritis
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseasesJune 8, 2020MelanomaPsoriasisPsoriatic Arthritis
TNF inhibitor plus methotrexate surpassed methotrexate monotherapy in PsAJune 8, 2020Psoriatic Arthritis
Most rheumatology drugs don’t increase COVID-19 hospitalization riskJune 4, 2020COVID-19 UpdatesPsoriatic Arthritis
Biologics yield low rates of skin clearance in real-world psoriasis studyJune 3, 2020PsoriasisPsoriatic Arthritis
‘Loss-frame’ approach makes psoriasis patients more agreeable to treatmentMay 29, 2020PsoriasisPsoriatic Arthritis
Psoriasis patients with mental illness report lower satisfaction with physiciansMay 15, 2020PsoriasisMixed TopicsPsoriatic Arthritis
